Loading...
Loading...
Centene Corporation
CNC today
announced that it has signed a definitive agreement to acquire Specialty
Therapeutic Care Holdings, Inc. (d/b/a AcariaHealth), one of the nation's
largest, independent, comprehensive specialty pharmacy companies, from
Enhanced Equity Funds and affiliates for $152 million. The transaction
consideration is anticipated to be financed through a combination of Centene
common stock, cash on hand and existing credit facilities. The acquisition is
expected to close in the first quarter of 2013, subject to regulatory approval
and other customary conditions. The Company expects the acquisition to be
neutral to earnings per share in the first 12 months following the
acquisition, excluding one-time transaction costs.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
We simplify the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in